Cardiology in Review
Overview
Cardiology in Review is a comprehensive journal that provides a concise and up-to-date overview of the latest advancements in the field of cardiology. It offers in-depth reviews, critical analyses, and expert perspectives on various topics, including cardiovascular diseases, diagnostic techniques, therapeutic interventions, and emerging research. This journal serves as a valuable resource for cardiologists, researchers, and healthcare professionals seeking to stay informed about the rapidly evolving landscape of cardiology.
Details
Details
Abbr.
Cardiol Rev
Start
1993
End
Continuing
Frequency
Bimonthly
p-ISSN
1061-5377
e-ISSN
1538-4683
Country
United States
Language
English
Specialty
Cardiology & Vascular Diseases
Metrics
Metrics
h-index / Ranks: 5603
65
SJR / Ranks: 7539
598
CiteScore / Ranks: 5670
4.60
JIF / Ranks: 5004
2.1
Recent Articles
1.
Raizada A, Parikh M, Mihatov N, Frishman W, Peterson S
Cardiol Rev
. 2025 Mar;
PMID: 40063845
The incidence of premature ventricular contractions (PVCs) in a structurally normal heart can result in clinically significant consequences, including PVC-induced cardiomyopathy. It is essential to consider the electrophysiologic characteristics of...
2.
Bolaji O, Bahar Y, Shah R, Bahar A, Oriaifo O, Lawrence I, et al.
Cardiol Rev
. 2025 Mar;
PMID: 40063839
Managing patients with acute myocardial infarction and concomitant intracerebral hemorrhage (ICH) is a complex challenge requiring a delicate balance between timely reperfusion and hemorrhagic risk mitigation. This state-of-the-art review comprehensively...
3.
Chrysant S
Cardiol Rev
. 2025 Mar;
PMID: 40052796
This study aims to present the current evidence on the antihypertensive and cardioprotective properties of potassium. Increased potassium intake has been associated with antihypertensive and cardioprotective effects demonstrated by many...
4.
Barris B, Karp A, Jacobs M, Frishman W
Cardiol Rev
. 2025 Mar;
PMID: 40047439
Cardiovascular disease (CVD) has remained the leading cause of death among adults for more than one hundred years. With persistently suboptimal outcomes and a profound economic burden on our healthcare...
5.
Eisenberg E, Frishman W, Aronow W
Cardiol Rev
. 2025 Mar;
PMID: 40047412
Radiation therapy is a widely used treatment for cancer, but it can have detrimental effects on the heart, leading to radiotherapy-induced cardiotoxicity. This condition has become an area of increasing...
6.
Goyal A, Ekelmans A, Cerjak J, Frishman W
Cardiol Rev
. 2025 Mar;
PMID: 40047411
Vasomotor symptoms (VMS), such as hot flashes and night sweats, are experienced by over 80% of women during menopause and can significantly impair quality of life. While hormone replacement therapy...
7.
Huhulea E, Huang L, Aifuwa E, Frishman W, Aronow W
Cardiol Rev
. 2025 Mar;
PMID: 40029056
Diabetic individuals of reproductive age face higher risks of poor pregnancy outcomes and abnormal fetal development. Approximately 4.5% of women of reproductive age have diabetes, with non-Hispanic Black women having...
8.
9.
Shahidi M
Cardiol Rev
. 2025 Feb;
PMID: 40019384
Hypoplastic left heart syndrome (HLHS) is a prevalent and lethal type of single ventricle anomaly. During early prenatal evaluations, left heart hypoplasia may be neglected due to its progressive features....
10.
Kallash M, Frishman W
Cardiol Rev
. 2025 Feb;
PMID: 40014468
Tadalafil is a phosphodiesterase inhibitor currently approved for use in erectile dysfunction (ED), benign prostatic hyperplasia (BPH), and pulmonary arterial hypertension (PAH). While tadalafil's benefits in ED and BPH have...